A carregar...
Neoadjuvant therapy for early-stage breast cancer: the clinical utility of pertuzumab
Approximately 20% of breast cancer patients harbor tumors that overexpress human epidermal growth factor receptor 2 (HER2; also known as ErbB2), a receptor tyrosine kinase that belongs to the epidermal growth factor receptor family of receptor tyrosine kinases. HER2 amplification and hyperactivation...
Na minha lista:
| Publicado no: | Cancer Manag Res |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4762586/ https://ncbi.nlm.nih.gov/pubmed/26937204 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S55279 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|